Following The Money: Institution’s Growing Stake In Sangamo Therapeutics Inc (NASDAQ: SGMO)
Sangamo Therapeutics Inc (SGMO) concluded trading on Thursday at a closing price of $1.27, with 8.17 million shares of worth about $10.38 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 28.26% during that period and on February 06, 2025 the price saw a […]
Following The Money: Institution’s Growing Stake In Sangamo Therapeutics Inc (NASDAQ: SGMO)
Sangamo Therapeutics Inc (SGMO) concluded trading on Thursday at a closing price of $1.23, with 6.11 million shares of worth about $7.52 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 75.71% during that period and on January 30, 2025 the price saw a […]
Sangamo Therapeutics Inc (NASDAQ: SGMO) Hogging The Spotlight Today
Currently, there are 208.62M common shares owned by the public and among those 199.18M shares have been available to trade. The company’s stock has a 5-day price change of -24.07% and 22.43% over the past three months. SGMO shares are trading 0.49% year to date (YTD), with the 12-month market performance up to 103.05% higher. […]
Do Sangamo Therapeutics Inc (NASDAQ: SGMO) Fit In A Value Investing Philosophy?
Currently, there are 208.62M common shares owned by the public and among those 199.18M shares have been available to trade. The company’s stock has a 5-day price change of -50.57% and 64.04% over the past three months. SGMO shares are trading 27.45% year to date (YTD), with the 12-month market performance up to 143.08% higher. […]
Sangamo Therapeutics Inc (SGMO) Volatility Spurs A Quest For Clarity
Currently, there are 208.62M common shares owned by the public and among those 199.18M shares have been available to trade. The company’s stock has a 5-day price change of -5.26% and 170.18% over the past three months. SGMO shares are trading 330.70% year to date (YTD), with the 12-month market performance up to 290.65% higher. […]
Sangamo Therapeutics Inc (NASDAQ: SGMO): Hunting Genuine Value In Market Debris
Currently, there are 208.62M common shares owned by the public and among those 199.09M shares have been available to trade. The company’s stock has a 5-day price change of -9.64% and 158.04% over the past three months. SGMO shares are trading 339.90% year to date (YTD), with the 12-month market performance up to 516.77% higher. […]
Reassessing The Changing Outlook For Sangamo Therapeutics Inc (SGMO)
Currently, there are 208.62M common shares owned by the public and among those 199.09M shares have been available to trade. The company’s stock has a 5-day price change of 32.25% and 217.30% over the past three months. SGMO shares are trading 386.84% year to date (YTD), with the 12-month market performance up to 515.12% higher. […]
Gains May Be On The Menu For Sangamo Therapeutics Inc (NASDAQ: SGMO)
Currently, there are 208.62M common shares owned by the public and among those 199.07M shares have been available to trade. The company’s stock has a 5-day price change of -9.30% and 131.10% over the past three months. SGMO shares are trading 258.92% year to date (YTD), with the 12-month market performance up to 302.06% higher. […]
Sangamo Therapeutics Inc (SGMO) Testing Investors’ Patience Right Now
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
Handle With Care: Sangamo Therapeutics Inc (NASDAQ: SGMO)
Currently, there are 166.79M common shares owned by the public and among those 154.22M shares have been available to trade. Insiders at the company have transacted a total of 41 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 15 of these insider trades were purchases, […]
